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OBJECTIVE—To test whether a theory-based, literacy, and culturally tailored self-management
intervention,LatinosenControl,improvesglycemiccontrolamonglow-incomeLatinoswithtype2
diabetes.
RESEARCH DESIGN AND METHODS—A total of 252 patients recruited from com-
munity health centers were randomized to the Latinos en Control intervention or to usual care.
The primarily group-based intervention consisted of 12 weekly and 8 monthly sessions and
targeted knowledge, attitudes, and self-management behaviors. The primary outcome was
HbA1c. Secondary outcomes included diet, physical activity, blood glucose self-monitoring,
diabetesknowledgeandself-efﬁcacy,andotherphysiologicalfactors(e.g.,lipids,bloodpressure,
and weight). Measures were collected at baseline and at 4- and 12-month follow-up. Change in
outcomes over time between the groups and the association between HbA1c and possible medi-
ators were estimated using mixed-effects models and an intention-to-treat approach.
RESULTS—A signiﬁcant difference in HbA1c change between the groups was observed at
4 months (intervention 20.88 [21.15 to 20.60] versus control 20.35 [20.62 to 0.07],
P , 0.01), although this difference decreased and lost statistical signiﬁcance at 12 months (inter-
vention 20.46 [20.77 to 20.13] versus control 20.20 [20.53 to 0.13], P = 0.293). The interven-
tion resulted in signiﬁcant change differences in diabetes knowledge at 12 months (P =0 . 0 0 1 ) ,
self-efﬁcacy (P = 0.001), blood glucose self-monitoring (P = 0.02), and diet, including dietary quality
(P=0.01),kilocaloriesconsumed(P,0.001),percentageoffat(P=0.003),andpercentageofsaturated
fat (P=0.04).ThesechangeswereinturnsigniﬁcantlyassociatedwithHbA1cchangeat12months.
CONCLUSIONS—Literacy-sensitive, culturally tailored interventions can improve diabetes
control among low-income Latinos; however, strategies to sustain improvements are needed.
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n the U.S., 10.4% of adult Latinos
compared with 6.6% of non-Latino
whiteshavetype2diabetes(1).Latinos
also have higher rates of diabetes-related
complications and are 1.6 times more
likely to die from diabetes compared
with non-Latino whites (2). Behavioral
self-management by patients is complex
but critical for glycemic control (3); how-
ever, socioeconomic, psychological,
social, and cultural factors inﬂuence
patients’ adherence to behavioral self-
management prescriptions. Interventions
tailored to address these inﬂuences may
enhance treatment adherence.
Behavioral interventions have shown
efﬁcacy for improving glucose control
among individuals with diabetes (4).
However, only two large randomized
clinical trials (RCTs) in the past decade
have examined the effectiveness of these
interventionsamonglow-incomeLatinos.
These RCTs were conducted in Texas (5)
and California (6), both of which are
states where Latinos are predominantly
Mexican American. Puerto Ricans, the
largest Latino group in the northeast U.S.,
have among the highest prevalence of di-
abetes among all Latinos at 12.6% (1) but
have been under-studied.
The increasing trend of diabetes
among Latinos coupled with a continued
growth of the Latino population in the
U.S. (7) and rapidly increasing economic
costs of diabetes to individuals and soci-
ety (8) make efforts to improve glycemic
control and secondary prevention of ut-
most priority. This study tested the im-
pact of a theory-based culturally tailored
literacy-sensitivediabetesself-management
intervention on glycemic control (HbA1c)
among low-income Latinos with diabetes.
Secondary outcomes included diet, physi-
cal activity, blood glucose self-monitoring,
diabetes knowledge and self-efﬁcacy, and
other physiological factors (e.g., lipids,
blood pressure, and weight).
RESEARCH DESIGN AND
METHODS—This RCT compared the
efﬁcacy of the Latinos en Control inter-
vention to that of an enhanced usual-care
condition (detailed methods described
previously [9]). The study was approved
by the institutional review boards of the
University of Massachusetts and Baystate
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ORIGINAL ARTICLEMedical Center. All participants provided
signed informed consent. We recruited
participants from ﬁve community health
centers.Eligibilitycriteriawereasfollows:
Latino ethnicity, age $18 years, docu-
mented diagnosis of type 2 diabetes; last
HbA1c (previous 7 months) $7.5%; abil-
itytowalk;notype1diabetesorhistoryof
ketoacidosis; no medical contraindica-
tions to participation; no use of glucocor-
ticoid therapy within the prior 3 months;
notcurrentlyparticipatinginacardiacre-
habilitation or formal weight loss pro-
gram; no plans to move out of the area
within the 12-month study period; access
to a telephone; ability and willingness to
provide informed consent (English or
Spanish); and physician approval to par-
ticipate.
A multistep screening and recruit-
ment process as described previously
(10) was implemented under a Health In-
surance Portability and Accountability
Act waiver with consent from the primary
care providers (PCPs) at the study sites.
Research coordinators screened partic-
ipants and obtained PCP approval for
participation of screened patients. The
coordinators sent letters signed by PCPs
informing patients about the study and
then contacted the patients to assess ﬁnal
eligibility, explain the study in greater
detail, and invite eligible individuals to
participate. Eligible and interested indi-
viduals were scheduled for a recruitment
visit where consent procedures were im-
plemented. After baseline assessments,
participants were randomized into the in-
tervention or control condition.
Randomization was at the individual
level and stratiﬁed by site, sex, HbA1c
level, and insurance status. Within each
strata, subjects were randomized in ran-
domly allocated blocks. Given the nature
of the study, we could not blind partici-
pants’ PCPs; however, providers were not




year-long program consisting of an in-
tensive phase of 12 weekly sessions and a
follow-up phase of 8 monthly sessions.
Using social-cognitive theory (SCT) (11)
as a framework, it targeted previously
identiﬁed needs in this population related
tokeySCTconstructs:diabetesknowledge,
attitudes (i.e., self-efﬁcacy or conﬁdence
in making changes), and self-management
behaviors (12–14). We addressed literacy
needs by simplifying complex concepts
(e.g.,apicture-basedfoodguide),minimiz-
ing didactic instruction, engaging subjects
in activities that reinforced key concepts
over time (e.g., “foods bingo”), and model-
ing and experiential teaching methods
(e.g., cooking lessons with participant in-
volvement and eating healthy meals at the
sessions). Cultural tailoring included the
use of an educational soap opera (soap
operas are popular in this population) to
introduce self-management information
and model attitudinal change and desired
behaviors in the context of culturally rel-
evant situations, use of bingo games (also
popular in this population) to reinforce
information taught, emphasis on making
traditional foods healthier via healthy
preparation methods, and addressing
family preferences among others. All par-
ticipants received a step counter and were
encouragedtoincreasetheirwalkingsteps
progressively. A color-coded graph dem-
onstratedideal,borderline,anddangerous
glucose levels. Participants received a glu-
cose meter and simple logs to track their
glucose values, diet, and physical activity.
Patients received both brief personalized
counseling, with feedback regarding their
logs and meter data, and assistance with
goal setting and problem solving of chal-
lenges. We encouraged attendance by
family members or friends living in the
same household.
The ﬁrst session was conducted as an
individual 1-h meeting in the partici-
pant’s home. We conducted the remain-
ing sessions in groups at centrally located
community settings (e.g., a Latino cen-
ter, a senior center, a YMCA site). Group
sessions lasted for approximately 2.5 h
(1sth:personalized counselingandcook-
ing; remaining time: group protocol and
meal). The intervention was guided by a
detailed protocol and delivered by a
trained team of two leaders and an assis-
tant (either a nutritionist or health educa-
torandtrained layindividualsorthree lay
individuals supervised by two investiga-
tors). Participants received reminder calls
on the evening before each session. An
earlier version of this intervention was
pilot-tested (15) for feasibility and poten-
tial impact.
The study diabetologist oversaw pa-
tient safety. Providers of patients who
exceeded a safety threshold (deﬁned by
the study team as two or more glucose
levels ,70 mg/dL, two or more glucose
levels $350 mg/dL, or one glucose level
$500mg/dLsincethepreviouslyattended
session) received an e-mail notiﬁcation
that contained a graph of the patient’s
glucose values downloaded from their
meter.
Participants in the usual care condi-
tion received no intervention. All provid-
ers (both conditions) received laboratory
results, including HbA1c,f a s t i n gb l o o d
glucose, and lipid proﬁles at baseline
and at 4 and 12 months, and were free
to provide care as deemed appropriate
or as routinely delivered.
Measures and data collection
Trained bilingual and bicultural research
staff blinded to the study condition con-
ducted assessments at baseline, postin-
tensiveintervention(4months),andat12
months. Patients were given a choice of
language(EnglishorSpanish),andsurvey
measures were administered orally.
Clinical measures. Fasting blood sam-
ples were collected for determination of
HbA1c and lipid panel. A measure of glu-
cose variability, the Average Daily Risk
Range (16), was obtained for participants
in the intervention condition using data
downloaded from glucose meters at each
intervention session. Blood pressure was
determined using the mean of two mea-
sures taken with a Dynamap XL auto-
mated BP monitor. Height and weight
andwaistcircumferenceweredetermined
using the mean of two measures obtained
using standard methods. Diabetes medi-
cations and dose were recorded directly
from the participants’ medication labels.
A medication intensity variable was con-
structed by assigning a low score for regi-
mens based on monotherapy with oral
agents and increasing the score as the
numberoforalagentsincreasedorinsulin
was included. The highest score corre-
sponded to regimens that included a
combinationoffast-acting andbasalinsu-
lin. Regimens with a total daily dose of
insulin of .1 unit/kg of the patient’s
weight received higher scores.
Behavioral measures. A trained reg-
istered dietitian made unannounced
telephone calls to obtain 24-h recalls of
dietary intake (17), physical activity
(18,19), andbloodglucoseself-monitoring.
Three recalls were administered at base-
line and 12 months (2 weekdays and
1 weekend day) and to a random subsam-
ple(56%)at4months(withtheremaining
completing a single recall at 4 months).
The 24-h recall of blood glucose self-
monitoring included three questions:
Do you monitor your blood glucose level?
Did you monitor your blood glucose yes-
terday? How many times did you monitor
your blood glucose yesterday from the
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survey questions regarding exercise habits
also were used: 1) “In the last 7 days, on
how many days did you walk for at least
10 min, without stopping, to exercise?” If
patientsreportedwalkingtoexercise,they
were asked, “About how many minutes
did you walk each time?” and 2) “In the
last 7 days, on how many days did you
do some other type of exercise for at least
20 min?”
Other diabetes-related measures. Dia-




previously pretested and adapted for the
target population (21). The research
team developed a 17-item tool to assess
self-efﬁcacy for dietary and physical ac-




Baseline characteristics between random-
ized groups were tested using t tests for
continuous variables and Fisher exact
tests for categorical variables. Attendance
trends were tested using a mixed-effect
logistic regression model with the indi-
vidual as a random effect. Outcomes
over time were compared using mixed-
effects regression models with the individ-
ual as the random effect. Linear regression
w a su s e df o rm e a n so fc o n t i n u o u so u t -
comes and logistic regression for propor-
tions of binary outcomes. We used a
random intercept and slope (slope versus
time) model in all cases. The test of group
multiplied by time interaction provided
thetestofthedifferencebetweeninterven-
tion and control in change in outcomes
over time. All estimated changes in out-
comes were derived from the estimated
mixed models. The association of HbA1c
and possible mediators was estimated
using a linear regression mixed-effect
model.Therandomeffectwastheindivid-
ual, and the model estimated the associa-
tion of change in HbA1c and change in
mediators (longitudinal association), con-
trolling for cross-sectional effects.
RESULTS
Participants
A total of 252 patients were enrolled and
participated in the study, with 128 ran-
domizedtothecontrolconditionand124
randomized to the intervention condi-
tion.(Aﬂowchartofpatientscreeningand
recruitment was published previously
[10]). The sample was largely middle-
aged, female, had a low literacy rate,
were of Puerto Rican descent, spoke
monolingualSpanish,werenotemployed
(including 61.7% who were self-reported
as disabled), and were poor (Table 1).
Mean baseline HbA1c was 9.0% (SD
1.87). Most had an unfavorable cardio-
metabolic proﬁle, including uncontrolled
blood glucose (86.9%) and obesity
(74.9%) and abnormal lipid proﬁles
(53.2% LDL cholesterol, 44.3% triglycer-
ides, and 81.7% HDL cholesterol), or hy-
pertension (67.7%). Most participants
reported using oral hypoglycemics or in-
sulin, with 48.8% using insulin. At base-
line, the groups were balanced on the
measured variables, with the exception
of a signiﬁcant difference in diastolic
blood pressure (76.34 6 9.9 versus
73.37 6 8.4 mmHg, control versus inter-
vention, respectively; P , 0.011). The
medication intensity score was slightly
but nonsigniﬁcantly higher in the control
group compared with the intervention
group at baseline (3.1 versus 2.7, respec-
tively; P = 0.07).
Attendance at the study intervention
was greater during the intensive phase
(68% of patients attended $6o f1 2
weekly sessions; 10% attended none)
compared with the follow-up phase
(18% attended $4 of 8 monthly sessions;
27% attended none). This decreasing
trend in attendance was signiﬁcant (P ,
0.001).
Figure 1 shows mean changes for
HbA1c at the 4- and 12-month follow-
ups for both groups. Linear mixed-model
resultsshowedameanchangeinHbA1cin
the intervention group of 20.88 (range
21.15 to 20.60) postintensive interven-
tion (at 4-month follow-up) and 20.46
(20.77 to 20.13) at the 12-month
follow-up. However, we also observed
mean changes in HbA1c in the control
group: 20.35 (20.62 to 0.07) at 4
months and 20.20 (20.53 to 0.13) at
12 months, diminishing the intervention
effect, which was signiﬁcant at 4 months
(20.53 [20.92 to 20.14], P . 0.008)
but not at 12 months (20.25 [20.72 to
0.22], P . 0.293). A signiﬁcant associa-
tion emerged between intervention atten-
dance and HbA1c, with greater session
attendance resulting in lower HbA1c out-
comeat12months(P=0.005).Changein
HbA1cwasinverselyassociatedwithbase-
line HbA1c in both groups (regression co-
efﬁcient0.42and 0.45 for thecontroland
the intervention condition, respectively;
P , 0.001). The percentage of partici-
pants with HbA1c ,7% at 4 months was
29.1% versus 12.4% in the intervention
versus control group, respectively (P =
0.013) and at 12 months 23% versus
16.2% (P = 0.233). Glucose variability
(average daily risk range values) among
intervention participants showed a signif-
icant decrease over the course of the in-
tervention (P = 0.0004).
As i g n i ﬁcant intervention effect was
evident for improvement in dietary qual-
ity, for reduction of total calories and
percentage of fat of total calories (P ,
0.01) at 4 and 12 months, and for reduc-
tion of percentage of saturated fat of total
caloriesat12months(P=0.04)(Table2).
The proportion of patients reporting
blood glucose self-monitoring two or
moretimesperdayincreasedsigniﬁcantly
in the intervention (from 59% at baseline
to 84.2% and 81.5% at 4 and 12 months,
respectively) compared with the control
group (from 55.7% at baseline to 62.1–
63.6% at 4 and 12 months, respectively)
(P =0 . 0 2a n dP = 0.023 for change com-
parisonsat4and12months).Therewasa
greater although nonsigniﬁcant increase
in the proportion of patients who self-
reported walking for exercise (yes/no) in
the intervention (61.3–88.4% and 70.9%
at baseline and at 4 and 12 months) com-
pared with the control condition (52.3–
70.9% and 66.4% at baseline and 4 and
12 months) (P = 0.057 and P =0 . 4 3 5f o r
change comparison at 4 and 12 months).
No signiﬁcant changes were observed for
metabolic equivalent or total time of
physical activity, time walking, or time
sitting. Likewise, we saw no signiﬁcant
intervention effects on lipids, blood pres-
sure, weight,orwaist circumference (data
not shown). Both groups showed signiﬁ-
cant increases in medication intensity at
12 months (0.32 in controls and 0.31 in
intervention, P =0 . 0 2a n dP = 0.03, re-
spectively), with no change differences
between groups.
Decreases in HbA1c at 12 months in
the intervention group were associated
with improvements in diet (speciﬁcally,
an increase in dietary quality [P = 0.036]
and decreased percentage of saturated fat
[P=0.003]),increasedbloodglucoseself-
monitoring (P = 07), increased diabetes
knowledge (0.001), and increased self-
efﬁcacy (P = 0.026).
CONCLUSIONS—This study showed
thatintensiveinterventionstailoredtothe
needs of low-income Latinos can result in
840 DIABETES CARE, VOLUME 34, APRIL 2011 care.diabetesjournals.org
Diabetes self-management for low-income LatinosTable 1—Sample demographic and clinical characteristics in the Latinos en Control study (n = 252)
Control Intervention Total P
n 128 124 252
Age (years) 0.492
18–44 22 (17.2) 19 (15.3) 41 (16.3)
45–54 35 (27.3) 40 (32.3) 75 (29.8)
55–64 47 (36.7) 36 (29.0) 83 (32.9)
$65 24 (18.8) 29 (23.4) 53 (21.0)
Sex 0.556
Male 32 (25.0) 27 (21.8) 59 (23.4)
Female 96 (75) 97 (78.2) 193 (76.6)
Education (n = 250) 0.414
#4th grade 39 (31) 31 (25.0) 70 (28.0)
5th–8th grade 33 (26.2) 37 (29.8) 70 (28.0)
9th–12th grade (not high school graduate) 27 (21.4) 21 (16.9) 48 (19.2)
$High school 27 (21.4) 35 (28.2) 62 (24.8)
Birthplace: Puerto Rico 110 (85.9) 111 (89.5) 221 (87.7) 0.445
Medical insurance 0.354
Public insurance 113 (88.3) 112 (90.3) 225 (89.3)
Commercial Insurance 10 (7.8) 5 (4.0) 15 (6.0)
Free care 4 (3.1) 3 (2.4) 7 (2.8)
No insurance 1 (0.8) 4 (3.2) 5 (2.0)
Employment status (n = 230) 0.336
Working full or part time 15 (12.9) 11 (9.6) 26 (11.3)
Unemployed/looking for a job 6 (5.2) 2 (1.8) 8 (3.5)
Disabled 68 (58.6) 74 (64.9) 142 (61.7)
Retired 10 (8.6) 15 (13.2) 25 (10.9)
Housewife 17 (14.7) 12 (10.5) 29 (12.6)
Self-reported household income ,10,000/year (n = 217) 63 (56.3) 57 (54.3) 120 (55.3) 0.786
Years since diabetes diagnosis (n =2 4 3 ) 0.170
0–5 36 (29.3) 40 (33.3) 76 (31.3)
6–10 37 (30.1) 22 (18.3) 59 (24.3)
11–15 23 (18.7) 23 (19.2) 46 (18.9)
$16 27 (22.0) 35 (29.2) 62 (25.5)
BMI (n = 251)* 0.857
Normal 6 (4.7) 9 (7.3) 15 (6.0)
Overweight 25 (19.5) 23 (18.7) 48 (19.1)
Obese I 45 (35.2) 39 (31.7) 84 (33.5)
Obese II 25 (19.5) 22 (17.9) 47 (18.7)
Obese III 27 (21.1) 30 (24.4) 57 (22.7)
HbA1c (%) 0.541
#7.0 16 (12.5) 17 (13.7) 33 (13.1)
7.1–8.0 32 (25.0) 30 (24.2) 62 (24.6)
8.1–9.0 21 (16.4) 28 (22.6) 49 (19.4)
9.1–10.0 24 (18.8) 25 (20.2) 49 (19.4)
.10.0 35 (27.3) 24 (19.4) 59 (23.4)
HbA1C above goal (.7.0%) 112 (87.5) 107 (86.3) 219 (86.9) 0.853
HDL cholesterol below goal (men ,45 mg/dL,
women ,55 mg/dL) 108 (84.4) 98 (79.0) 206 (81.7) 0.328
LDL cholesterol above goal of .100 mg/dL† 62 (50.4) 68 (56.2) 130 (53.3) 0.373
Triglycerides above goal (men .150 mg/dL,
women .35 mg/dL) 58 (45.3) 55 (44.4) 113 (44.8) 0.900
Blood pressure above goal (systolic .130 mmHg or
diastolic .80 mmHg)‡ 91 (71.1) 79 (64.2) 170 (67.7) 0.281
High waist circumference (men .40”,w o m e n.35”)‡ 121 (94.5) 106 (86.2) 227 (90.4) 0.031
Diabetes medication regimen 0.221
Insulin alone 12 (9.4) 11 (8.9) 23 (9.1)
Insulin plus oral medication 58 (45.3) 42 (33.9) 100 (39.7)
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ments in glucose control and glucose
variability. However, strategies to sustain
these improvements are needed. The
clinical signiﬁcance of the impact of this
intervention is considerable in light of the
UK Prospective Diabetes Study (UKPDS)
data showing that, for every percentage
point decrease in HbA1c, there was a 35%
reduction in risk of diabetes complica-
tions (22). Furthermore, there appears
to be no sharp threshold for the clinical
importance of reducing HbA1c level,
which even at levels associated with insu-
lin resistance but not clinical diabetes is
still a marker for increased risk of cardio-
vascular disease (23).
This theory-based intervention tar-
geting patients’ diabetes knowledge, self-
efﬁcacy, and self-management behaviors
was successful in producing signiﬁcant
improvements in all three targets areas.
Furthermore, these improvements were
signiﬁcantly associated with HbA1c at 12
months,showingthatthetheoreticalcon-
structs mediated the effect between the
intervention and HbA1c. Improvements
in knowledge and self-efﬁcacy suggest
that literacy-sensitive materials and strat-
egies can bring about important and
needed changes. Likewise, the focus on
skills building through hands-on activities
may have facilitated the development of
self-efﬁcacy and behavioral skills needed
to implement the newly acquired knowl-
edge. Of particular interest were the die-
tary change ﬁndings and their mediating
role in the observed improvement in gly-
cemic control.The maintenance ofdietary
changesatthe12-monthfollow-upareen-
couraging given the common negative
attitudes toward dietary change in this
population (13,14). Previous studies
have not assessed the impact of inter-
vening to promote dietary change among
Latinos with diabetes (5,6). Our ﬁndings
thatself-monitoringtwiceperdayormore
was associated with improvements in glu-
cose control is also relevant because
the importance of blood glucose self-
monitoring among patients with type 2
diabetes has been questioned (24). Our
emphasis on teaching participants to use
glucose data to modify their diet intake or
their activity may have contributed to our
ﬁndings. The lack of an important inter-
vention impact on physical activity may
reﬂect the relatively weaker emphasis on
exercise intheprotocolandprobablycon-
tributed tothenonsigniﬁcantintervention





during the follow-up phase of the inter-
ventionandcorrelatedwiththedecreased
impact of the intervention over time.
While less than ideal, attendance rates
reﬂect the reality of many health centers
serving low-income populations (i.e.,
typically high cancellation and no-show
rates). In contrast to efﬁcacy studies,
which recruit only highly motivated in-
dividuals (i.e., those able to demonstrate
that they can adhere to study protocols
before being considered for study enroll-
ment),orclinicaltrialswithadvertisement-
based recruitment methods (likely to
recruit self-selected populations), we re-
cruited from a general pool of patients
with diabetes from health centers serving
low-income communities, often regarded
as “hard to reach.” A third factor contrib-
uting to the reduced change differences
between intervention and control condi-
tions was the slight improvement in
HbA1c observed in the control group.
This ﬁnding is consistent with those of
previous trials (25), suggesting that
Table 1—Continued
Control Intervention Total P
Oral medications alone 49 (38.3) 63 (50.8) 112 (44.4)
No medications 9 (7.0) 8 (6.5) 17 (6.7)
Test blood glucose at least twice/day (n = 243) 68 (55.3) 72 (60.0) 140 (57.6) 0.517
Continuous variables
HbA1c (%) 9.11 6 2.0 8.85 6 1.8 8.98 6 1.9 0.261
BMI (kg/m
2)‡ 34.52 6 6.5 35.02 6 7.4 34.76 6 6.9 0.568
HDL cholesterol (mg/dL) 43.66 6 9.1 44.98 6 9.6 44.31 6 9.3 0.263
LDL cholesterol (mg/dL)† 104.89 6 37.5 108.45 6 38.7 106.65 6 38.0 0.466
Triglycerides (mg/dL) 159.32 6 101.9 152.66 6 119.5 156.04 6 110.8 0.375§
Systolic blood pressure (mmHg)‡ 139.49 6 18.1 136.39 6 15.4 137.97 6 16.9 0.146
Diastolic blood pressure (mmHg)‡ 76.34 6 9.9 73.37 6 8.4 74.89 6 9.3 0.011
Waist circumference (cm)‡ 111.77 6 13.4 111.58 6 14.5 111.68 6 13.9 0.914
Alternative healthy eating index (n = 238) 30.95 6 7.8 29.43 6 7.6 30.21 6 7.7 0.131
T o t a lk c a l( n = 238) 1,666.92 6 521.5 1,737.04 6 617.4 1,701.10 6 570.1 0.344
%F a t( n = 238) 29.73 6 5.4 30.5 6 6.5 30.11 6 5.9 0.322
% SFA (n = 238) 9.56 6 2.3 9.69 6 2.7 9.63 6 2.5 0.681
% Carbohydrates (n = 238) 53.08 6 7.1 52.75 6 7.2 52.92 6 7.1 0.720
Knowledge score 0.61 6 0.1 0.59 6 0.2 0.60 6 0.1 0.403
Self-efﬁcacy score 2.86 6 0.6 2.79 6 0.5 2.82 6 0.6 0.309
Diabetes medication intensity score 3.11 6 1.7 2.71 6 1.7 2.91 6 1.7 0.053§
Total physical activity (MET-h/day)¶ 13.08 6 6.9 12.12 6 6.2 12.61 6 6.6 0.263
Total physical activity duration (h/day)¶ 5.00 6 2.3 4.90 6 2.3 4.95 6 2.3 0.748
Walking (h/day)¶ 0.12 6 0.3 0.15 6 0.4 0.13 6 0.4 0.147§




(BMI 30– 34.9 kg/m
2), obese class II (BMI 35– 39.9 kg/m
2), and obese class III (BMI $40 kg/m
2). †n =2 4 4 .‡n = 251. §Rank-sum test. ¶n =2 3 7 .
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of any intervention, produces glucose
control improvements. As in this study,
such improvements are greater among
individuals with higher baseline HbA1c.
With regression to the mean ruled
outasapossibleexplanationforthisphe-
nomenon (3), other mechanisms possibly
accounting for HbA1c improvements in-
clude contact and attention from research
staff, information discussed during the
screening, consenting and assessment ses-
sions, and patient motivation. Laboratory
results mailed to patients’ providers also
could have inﬂuenced outcomes.
A limitation of this study was the self-
reported nature of the behavioral data
(diet and blood glucose self-monitoring).
Inaddition,wewereunabletoobjectively
measure physician prescription patterns




showed no differences at baseline or over
time between the intervention and the
control groups. Another limitation was
the lack of blood glucose variability for
t h eu s u a l - c a r eg r o u p .
To our knowledge, this is the ﬁrst
large RCT to test a culturally tailored,
literacy-sensitivediabetesself-management
intervention for low-income Spanish-
speaking Latinos of Caribbean origin. Un-
like the two previous studies of diabetes
interventions targeting Latinos (5,6), this
study recruited patients from real-world
clinical settings; included comprehensive
assessments of clinical, behavioral and
theory-based constructs; and included as-
sessment of factors mediating HbA1c im-
provements. With currently climbing
rates of obesity, the prevalence of diabetes
Table 2—Changes in outcomes at 4-month and 12-month follow-ups in the Latinos en Control study (n = 252)
Change from baseline Control Intervention Intervention effect
Test of difference for
intervention vs. control
AHEI score
4m o n t h s 0 . 7 6( 20.96 to 2.48) 5.05 (3.30–6.79) 4.29 (1.84–6.74) 0.001
1y e a r 1 . 0 4( 20.52 to 2.60) 3.87 (2.25–5.49) 2.83 (0.58–5.08) 0.014
Kcal
4m o n t h s 9 4 . 6( 24.2 to 193.4) 2231.3 (2331.4 to 2131.1) 2325.9 (2466.5 to 2185.2) ,0.001
1y e a r 9 7 . 9( 24.4 to 200.2) 2213.7 (2319.6 to 2107.8) 2311.6 (2458.8 to 2164.4) ,0.001
%F a t
4m o n t h s 20.57 (22.10 to 0.97) 23.88 (25.44 to 22.33) 23.32 (25.50 to 21.13) 0.003
1y e a r 20.54 (21.77 to 0.70) 23.22 (24.51 to 21.94) 22.68 (24.47 to 20.90) 0.003
%S F A
4m o n t h s 20.31 (20.89 to 0.27) 21.07 (21.65 to 20.48) 20.75 (21.58 to 0.07) 0.073
1y e a r 20.40 (20.93 to 0.12) 21.19 (21.74 to 20.65) 20.79 (21.55 to 20.03) 0.041
%C H O
4m o n t h s 0 . 2 7( 21.47 to 2.00) 1.75 (20.01 to 3.51) 1.49 (20.98 to 3.95) 0.237
1y e a r 0 . 0 1( 21.46 to 1.49) 1.38 (20.15 to 2.92) 1.37 (20.76 to 3.50) 0.207
Diabetes knowledge
4 months 0.039 (0.015–0.063) 0.083 (0.059–0.107) 0.044 (0.011–0.078) 0.010
1 year 0.033 (0.009–0.057) 0.089 (20.065–0.113) 0.056 (0.022–0.090) 0.001
Self-efﬁcacy
4 months 0.132 (0.040–0.219) 0.448 (0.362–0.534) 0.316 (0.194–0.439) ,0.001
1 year 0.213 (0.113–0.313) 0.448 (0.0348–0.548) 0.235 (0.093–0.376) 0.001
Data are mean differences (range) unless otherwise indicated. AHEI, Alternative Healthy Eating Index (measure of dietary quality); SFA, saturated fatty acids; CHO, carbohydrate.
Figure 1—Mean differences in HbA1c level at 4- and 12-month follow-ups for the intervention
and control conditions of the Latinos en Control study (n = 252). (A high-quality color repre-
sentation of this ﬁgure is available in the online issue.)
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Rosal and Associatesand its associated complications will con-
tinue to increase among Latinos. Future
studies will need to examine innovative
ways to enhance diabetes self-management,
especially long-term glycemic control, and
the cost-effectiveness of these interventions.
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